BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 30734905)

  • 1. HIV Eradication Strategies: Implications for the Central Nervous System.
    Veenhuis RT; Clements JE; Gama L
    Curr HIV/AIDS Rep; 2019 Feb; 16(1):96-104. PubMed ID: 30734905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Potential of the CNS as a Reservoir for HIV-1 Infection: Implications for HIV Eradication.
    Fois AF; Brew BJ
    Curr HIV/AIDS Rep; 2015 Jun; 12(2):299-303. PubMed ID: 25869939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Quantitative Approach to SIV Functional Latency in Brain Macrophages.
    Abreu C; Shirk EN; Queen SE; Mankowski JL; Gama L; Clements JE
    J Neuroimmune Pharmacol; 2019 Mar; 14(1):23-32. PubMed ID: 30167896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspective on potential impact of HIV central nervous system latency on eradication.
    Chan P; Ananworanich J
    AIDS; 2019 Dec; 33 Suppl 2():S123-S133. PubMed ID: 31090545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research.
    Churchill MJ; Cowley DJ; Wesselingh SL; Gorry PR; Gray LR
    J Neurovirol; 2015 Jun; 21(3):290-300. PubMed ID: 25060300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phylogenetics and Phyloanatomy of HIV/SIV Intra-Host Compartments and Reservoirs: The Key Role of the Central Nervous System.
    Salemi M; Rife B
    Curr HIV Res; 2016; 14(2):110-20. PubMed ID: 26511341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV reservoirs and strategies for eradication.
    Smith MZ; Wightman F; Lewin SR
    Curr HIV/AIDS Rep; 2012 Mar; 9(1):5-15. PubMed ID: 22249405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Strategies for Elimination of HIV-1 Latent Reservoirs Using Chemical Compounds Targeting Host and Viral Factors.
    Jean MJ; Fiches G; Hayashi T; Zhu J
    AIDS Res Hum Retroviruses; 2019 Jan; 35(1):1-24. PubMed ID: 30351168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mathematical Models of HIV Latency.
    Hill AL
    Curr Top Microbiol Immunol; 2018; 417():131-156. PubMed ID: 29164341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglial Cells: The Main HIV-1 Reservoir in the Brain.
    Wallet C; De Rovere M; Van Assche J; Daouad F; De Wit S; Gautier V; Mallon PWG; Marcello A; Van Lint C; Rohr O; Schwartz C
    Front Cell Infect Microbiol; 2019; 9():362. PubMed ID: 31709195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mouse viral outgrowth assay: avatars for the detection of HIV-1 reservoirs.
    Metcalf Pate KA; Blankson JN
    Retrovirology; 2017 Nov; 14(1):52. PubMed ID: 29157283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.
    Avalos CR; Abreu CM; Queen SE; Li M; Price S; Shirk EN; Engle EL; Forsyth E; Bullock BT; Mac Gabhann F; Wietgrefe SW; Haase AT; Zink MC; Mankowski JL; Clements JE; Gama L
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenge of viral reservoirs in HIV-1 infection.
    Blankson JN; Persaud D; Siliciano RF
    Annu Rev Med; 2002; 53():557-93. PubMed ID: 11818490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Eradication: Early Trials (and Tribulations).
    Spivak AM; Planelles V
    Trends Mol Med; 2016 Jan; 22(1):10-27. PubMed ID: 26691297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV pharmacology: barriers to the eradication of HIV from the CNS.
    McGee B; Smith N; Aweeka F
    HIV Clin Trials; 2006; 7(3):142-53. PubMed ID: 16880170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring the Frequency of Latent HIV-1 in Resting CD4⁺ T Cells Using a Limiting Dilution Coculture Assay.
    Laird GM; Rosenbloom DI; Lai J; Siliciano RF; Siliciano JD
    Methods Mol Biol; 2016; 1354():239-53. PubMed ID: 26714716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular vesicle-mediated intercellular communication in HIV-1 infection and its role in the reservoir maintenance.
    Olivetta E; Chiozzini C; Arenaccio C; Manfredi F; Ferrantelli F; Federico M
    Cytokine Growth Factor Rev; 2020 Feb; 51():40-48. PubMed ID: 31926807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
    Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
    mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review of Current Strategies Towards the Elimination of Latent HIV-1 and Subsequent HIV-1 Cure.
    Maina EK; Adan AA; Mureithi H; Muriuki J; Lwembe RM
    Curr HIV Res; 2021; 19(1):14-26. PubMed ID: 32819259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The search for a cure for persistent HIV reservoirs.
    Lafeuillade A; Stevenson M
    AIDS Rev; 2011; 13(2):63-6. PubMed ID: 21587339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.